Assistance Publique - Hôpitaux de Paris: Embolism trials

The registry lists 13 Embolism studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 3 3Phase 4 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism RiskNot yet recruitingNCT05487950Phase 4
• Prospective Cohort Study of Patients With Infective Endocarditis at Pitié-Salpêtrière HospitalRecruitingNCT04992923
• Effect of a Global Simplified Strategy on Thromboembolic Events in Emergency Department Patients with Suspected Pulmonary EmbolismCompletedNCT06190392Not applicable
• A Prospective Study for the Treatment of Severe Pulmonary Embolism With Pharmacodynamic ThrombectomyStatus unknownNCT04318782Not applicable
• Modified Strategy to Safely Rule Out Pulmonary Embolism in the Emergency DepartmentCompletedNCT04032769Not applicable
• Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH)CompletedNCT03719027Not applicable
• Early Valve Surgery Versus Conventional Treatment in Infective Endocarditis Patients With High Risk of EmbolismActive, not recruitingNCT03718052Not applicable
• PERC Rule to Exclude Pulmonary Embolism in the Emergency DeparmentCompletedNCT02375919Not applicable
• Diuretic Versus Placebo in Pulmonary EmbolismStatus unknownNCT02268903Phase 3
• Magnetic Resonance Diagnosis of Pulmonary EmbolismTerminatedNCT01077778
• PEITHO Pulmonary Embolism Thrombolysis StudyCompletedNCT00639743Phase 3
• Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic AcidCompletedNCT00603317Phase 4
• Aortic Arch Related Cerebral Hazard Trial (ARCH)CompletedNCT00235248Phase 3